Trump targets deals in pharma, AI, energy, mining before midterm elections

NEW YORK, October 2 – Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its cholesterol drug Lipitor; and London-based AstraZeneca to consider a new headquarters in the U.S., according to two sources.